Breast Cancer Core Needle Biopsy Market Size, Share, and Growth Analysis, By Image-Guidance Technology (Ultrasound-Guided, Stereotactic-Guided), By End-User (Hospitals, Cancer Research Centers), By Product Focus, By Region - Industry Forecast 2026-2033

Global Breast Cancer Core Needle Biopsy Market size was valued at USD 873.3 Million in 2024 and is poised to grow from USD 916.44 Million in 2025 to USD 1347.82 Million by 2033, growing at a CAGR of 4.94% during the forecast period (2026-2033).

The breast cancer core needle biopsy market is primarily driven by a global focus on early detection and minimally invasive procedures, leading to a shift from surgical excision to percutaneous sampling. This market encompasses biopsy needles, guidance systems, and imaging integration used for tissue acquisition, essential for accurate histopathology and molecular testing. Enhanced diagnostic techniques, including stereotactic, ultrasound, and MRI guidance, have increased adoption and reduced the need for repeat procedures by providing better visualization. The integration of image-guided technologies promotes outpatient biopsies, lowering costs and accelerating treatment decisions. In emerging markets, mobile ultrasound and training initiatives have elevated screening efforts, presenting opportunities for manufacturers to supply comprehensive solutions. Additionally, AI innovations enhance diagnostic precision, streamlining workflows, and improving overall market efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Cancer Core Needle Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Breast Cancer Core Needle Biopsy Market Segments Analysis

Global breast cancer core needle biopsy market is segmented by image-guidance technology, end-user, product focus and region. Based on image-guidance technology, the market is segmented into Ultrasound-Guided, Stereotactic-Guided and MRI-Guided. Based on end-user, the market is segmented into Hospitals, Cancer Research Centers, Diagnostic Centers and Academic Institutes. Based on product focus, the market is segmented into Automated Core Needle Devices, Semi-automated Devices and Manual Biopsy Needles. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Breast Cancer Core Needle Biopsy Market

The global market for breast cancer core needle biopsy is significantly influenced by the growing initiatives aimed at promoting both public and provider-led screening programs, which have enhanced the detection of suspicious breast lesions. As awareness and recommendations for regular mammography and follow-up imaging increase, there is a heightened need for accurate diagnostic tools, particularly minimally invasive core needle biopsy systems. This heightened demand propels the acquisition of advanced biopsy needles and associated devices. It also emphasizes the importance of training and standardizing protocols, encouraging manufacturers to focus on making these technologies more accessible and efficient in clinical settings.

Restraints in the Global Breast Cancer Core Needle Biopsy Market

The Global Breast Cancer Core Needle Biopsy market faces significant challenges due to fragmented reimbursement policies and inconsistent insurance coverage for these procedures. This unpredictability can lead healthcare providers and administrators to hesitate in investing in advanced biopsy equipment and necessary training. In situations where reimbursement fails to meet procedural costs, healthcare facilities may choose to prioritize existing equipment over new acquisitions, hindering market growth. Additionally, unclear or restrictive payment pathways can dissuade manufacturers from entering specific markets or launching premium technologies, ultimately impeding the overall adoption of innovations that could enhance access and patient outcomes in breast cancer diagnosis.

Market Trends of the Global Breast Cancer Core Needle Biopsy Market

The Global Breast Cancer Core Needle Biopsy market is experiencing a significant transformation driven by the rising preference for minimally invasive procedures. Clinicians and patients are increasingly gravitating towards core needle biopsies due to their advantages in reducing recovery times and preserving surrounding tissue. This trend promotes outpatient care, enhances patient comfort, and improves cosmetic results, aligning closely with advancements in imaging technology. Consequently, there is a growing demand for devices that offer precise sampling and ergonomic usability. In response, manufacturers are innovating with enhanced needle designs and comprehensive training initiatives, fostering broader clinical adoption and improved care coordination among multidisciplinary teams.